
Global Ayurvedic Market
Global Ayurvedic Market Size, Share, Competitive Landscape and Trend Analysis Report by Product Type, Application, End User and Distribution Channel: Global Opportunity and Industry Forecast (2025-2030)
Report ID:
1136
Industry:
Healthcare
Published on:
Jan 2026
Ayurvedic Market Summary
Global Ayurvedic Market had a value of USD 13.64 Billion in 2024 and expected it to hit USD 31.55 Billion by 2030, with a CAGR of 15 % during the forecast period.
Ayurvedic Industry Trends and Analytical Insights –
Preventive healthcare and wellness applications are among the fastest-growing segments, driven by rising awareness of immunity enhancement, lifestyle disorder management, stress relief, and the growing integration of Ayurvedic products into nutraceuticals, functional foods, and personal care.
Asia-Pacific emerged as the leading regional market, fueled by India’s expanding AYUSH ecosystem, increasing export demand for herbal medicines, favorable policy support, and growing adoption of Ayurveda-based therapies across Southeast Asia, the Middle East, and selected Western markets.
Leading Ayurvedic companies such as Dabur, Patanjali, Himalaya, Baidyanath, and Emami continue to shape the Ayurvedic market through strong brand equity, extensive distribution networks, and increasing investments in standardized, research-backed herbal formulations.
Market Size & Forecast:
Market Size 2024: USD 13.64 Billion
Projected Market Size 2030: USD 31.55 Billion
CAGR (2024-2030): 15%
Asia Pacific dominated the market in 2024
Ayurvedic Market Overview
The Ayurvedic market in India forms the backbone of the broader AYUSH sector and is strongly supported by government policy, domestic consumption, and export growth. According to data published by the Ministry of AYUSH and the Ministry of Commerce, India hosts thousands of licensed Ayurvedic manufacturing units, including a large base of MSMEs and several large, GMP-certified companies producing classical medicines, proprietary formulations, nutraceuticals, and personal care products. The sector has expanded significantly over the last decade, with government statements indicating that the AYUSH industry has grown multiple times since the mid-2010s, driven by rising demand for preventive healthcare, immunity-boosting products, and natural remedies. On the trade front, India exported over ₹5,500 crore worth of AYUSH and herbal products in FY2023–24, with Ayurveda accounting for a substantial share of formulations, extracts, and finished goods supplied to markets in the US, Europe, Middle East, Southeast Asia, and Africa, as per Department of Commerce export statistics. Ayurvedic production is further supported by public investment through the Ministry of AYUSH budget (nearly ₹4,000 crore annually), funding institutions such as CCRAS, pharmacopoeia development, quality control laboratories, and cultivation of medicinal plants under the National AYUSH Mission. In addition to pharmaceuticals, Ayurveda contributes significantly to healthcare services, wellness tourism, and hospital-based therapies, reinforcing its role not only as a traditional medicine system but as an economically significant healthcare industry integrated into India’s export, manufacturing, and public health ecosystems.

Ayurvedic Industry Dynamics
The Ayurvedic industry in India is being driven by a combination of rising health consciousness, strong government support, and expanding global demand for natural healthcare solutions. Increasing preference for preventive and holistic healthcare has significantly boosted domestic consumption of Ayurvedic medicines, immunity enhancers, nutraceuticals, and wellness products. This demand is reinforced by sustained policy backing from the Government of India, with the Ministry of AYUSH receiving nearly ₹4,000 crore in annual budgetary allocation, supporting research, education, quality control laboratories, and medicinal plant cultivation under the National AYUSH Mission. On the supply side, the industry has witnessed rapid expansion in manufacturing capacity, with tens of thousands of AYUSH-related MSMEs operating across India, reflecting growing entrepreneurship and localized production. Export performance further strengthens the sector, as AYUSH and herbal product exports crossed ₹5,500 crore in FY2023–24, with rising shipment volumes indicating increasing acceptance of Ayurvedic formulations in markets such as the US, Europe, Middle East, and Southeast Asia.
At the same time, the industry is undergoing structural transformation through standardization, scientific validation, and product diversification, shaping key market trends and long-term opportunities. There is a clear shift toward value-added products, including evidence-backed proprietary medicines, functional foods, herbal cosmetics, and wellness services, alongside traditional classical formulations. States such as Gujarat and Kerala are emerging as manufacturing hubs, with a growing number of GMP-compliant Ayurvedic units, improving export readiness and regulatory compliance. Looking ahead, significant opportunities exist in export-led growth, wellness tourism, integration of Ayurveda with mainstream healthcare systems, and digital health platforms offering personalized Ayurvedic solutions. Supported by rising global interest in traditional medicine and continued government investment in quality and research infrastructure, the Ayurvedic industry is positioned to play an increasingly important role in India’s healthcare economy and international trade landscape.
Ayurvedic Market Segment Analysis
Based on Product Type, the market is segmented into Classical Ayurvedic Medicines and Proprietary / Patent Formulations. Classical Ayurvedic Medicines segment dominated the market in 2024 and is expected to hold the largest Ayurvedic Market share over the forecast period. Classical Ayurvedic medicines dominate the market because they are formulated strictly according to authoritative Ayurvedic texts and are widely prescribed in government and private AYUSH hospitals, dispensaries, and clinics across India. Their dominance is reinforced by strong consumer trust, long-term clinical usage, and inclusion in public healthcare programs, particularly under the Ministry of AYUSH. Additionally, classical formulations are often cost-effective and suitable for chronic and lifestyle-related disorders, leading to consistent demand from both rural and urban populations.

Based on Application, the market is segmented into Therapeutic Healthcare, Preventive Healthcare & Immunity, and Wellness & Rejuvenation. Preventive Healthcare & Immunity segment dominated the market in 2024 and is expected to hold the largest Ayurvedic Market share over the forecast period. The preventive healthcare and immunity enhancement segment dominates due to rising awareness of holistic wellness and disease prevention, especially following increased public focus on immune health. Ayurvedic concepts such as Rasayana therapy and daily wellness regimens (Dinacharya and Ritucharya) align well with modern preventive health trends. This segment benefits from high repeat consumption, over-the-counter availability, and strong government advocacy for preventive healthcare, making it one of the most widely adopted and fastest-growing applications within the Ayurvedic market.

Ayurvedic Market Regional Insight
The Asia-Pacific (APAC) region is the dominant regional market for Ayurveda, accounting for the largest share of the global Ayurvedic industry—approximately 45% of total market value in 2025—driven by deep cultural acceptance, established production infrastructure, and strong domestic consumption especially in India, Sri Lanka, and Nepal. India, being the birthplace of Ayurveda and the major production hub, contributes a significant portion of this share, with around over 60% of regional consumers regularly using herbal remedies and traditional formulations, and India itself representing more than half of regional consumption. The region’s dominance is also supported by government initiatives like the Ministry of AYUSH and National AYUSH Mission, which strengthen regulatory frameworks and promote traditional medicine systems at both domestic and international levels.
The Ayurvedic market in India exhibits notable regional diversity, with certain states emerging as production and demand hubs while others benefit from wellness tourism and exports. For example, Gujarat has become a major manufacturing centre for Ayurvedic medicines, with the state government approving over 200 new Ayurvedic units between 2021–25, taking the total number of GMP-compliant plants to more than 1,000, driven by strong domestic demand and export potential. Central India also plays a significant role; in Indore, Madhya Pradesh, around 240 Ayurvedic manufacturing units contribute to a local market valued at over ₹1,000 crore, supplying products across northern and western states and signalling cluster-level growth potential.
In the south, Kerala stands out as a key regional market for Ayurvedic wellness and medical tourism, with an estimated 7.4 lakh foreign visitors in 2024 opting for Ayurveda-based therapies and wellness programmes, contributing approximately ₹13,500 crore in revenue, up from ₹10,800 crore the previous year. This highlights the state’s strength not only in product consumption but also in service-oriented Ayurveda, including Panchakarma and wellness centres.
At a broader level, national export data reflects geographical impact on international trade: AYUSH and herbal exports grew to ₹5,907 crore (~US$689 million) in FY25, up from ₹5,580 crore in FY24, with export volumes increasing nearly 21.5 % year-on-year, indicating expanding reach beyond domestic markets by suppliers from multiple regions. Collectively, these regional dynamics illustrate how industrial clusters (Gujarat, Madhya Pradesh), wellness tourism (Kerala), and export-oriented supply chains are shaping the overall Ayurvedic landscape in India, making the sector both domestically significant and globally competitive.
Ayurvedic Market Competitive Landscape
The Ayurvedic market competitive landscape is characterized by the presence of a few large, well-established companies alongside a highly fragmented base of small and medium manufacturers, particularly in India. Leading players such as Dabur India, Patanjali Ayurved, Himalaya Wellness, Emami (Zandu), and Baidyanath dominate the organized segment through strong brand equity, diversified product portfolios, and extensive distribution networks. Dabur and Himalaya generate annual revenues exceeding US$1 billion, supported by large-scale GMP-certified manufacturing facilities, in-house research capabilities, and exports to over 100 countries. Patanjali has emerged as a mass-market leader by integrating Ayurvedic medicines with FMCG products, leveraging backward integration in herbal sourcing, large production plants, and a nationwide retail footprint to achieve high volumes at competitive pricing.
Ayurvedic Market Scope:

Ayurvedic Market Major Key Players includes
2. Dabur India Ltd.
4. Emami Group
5. Baidyanath Group
6. Vicco Laboratories (Vicco Group)
8. Hamdard Laboratories
9. Charak Pharma Pvt. Ltd.
10. Amrutanjan Healthcare Ltd.
11. Sandu Pharmaceuticals Ltd.
12. Maharishi Ayurveda Products
13. Lotus Herbals
14. Kerry Group (Natreon Inc.)
15. Bio Veda Action Research Co.
16. Medimix (AVA Group)
17. Forest Essentials
18. Kama Ayurveda
19. Herbal Hills
20. Jeena Sikho Lifecare Limited
Frequently asked Qusetions:
1. Which product type dominates the Ayurvedic market?
Ans: Classical Ayurvedic medicines dominate due to strict formulation based on authoritative texts, widespread prescriptions in hospitals, and strong consumer trust.
2. Which region holds the largest share of the Ayurvedic market?
Ans: The Asia-Pacific (APAC) region, led by India, accounts for approximately 45% of the global market, supported by domestic consumption, production infrastructure, and government initiatives.
3. What are the main distribution channels in Ayurvedic Market?
Ans: Key channels include Pharmacies & AYUSH stores, Company-owned outlets, Modern Trade & FMCG retail, and E-commerce/D2C platform.
4. What trends are shaping the Ayurvedic market?
Ans: Trends include value-added products, evidence-based proprietary formulations, integration with functional foods and cosmetics, digital health platforms, and scientific validation of therapies.
5. How is export contributing to the Ayurvedic market?
Ans: India exported over ₹5,900 crore (~US$689 million) in AYUSH and herbal products in FY25, with nearly 21.5% year-on-year growth, reflecting increasing global demand.